Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12195
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLee, Mardianaen
dc.contributor.authorRoberts, Matthew Aen
dc.contributor.authorSmith, Maree-Rossen
dc.contributor.authorChuen, Jasonen
dc.contributor.authorMount, Peter Fen
dc.date.accessioned2015-05-16T01:51:00Z
dc.date.available2015-05-16T01:51:00Z
dc.date.issued2014-04-26en
dc.identifier.citationBlood Purification 2014; 37(3): 163-71en
dc.identifier.govdoc24777074en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12195en
dc.description.abstractOptimal timing of arteriovenous fistula (AVF) surgery in chronic kidney disease (CKD) is uncertain.A single-centre retrospective study of pre-dialysis CKD patients having first AVF surgery.The median estimated glomerular filtration rate (eGFR) at the time of AVF surgery in 100 patients was 15 ml/min/1.73 m(2), with patients classified as having an early AVF if eGFR was >15 ml/min/1.73 m(2) (n = 46) or a late AVF if eGFR was ≤15 ml/min/1.73 m(2) (n = 54). In the eGFR ≤15 group, 81% of patients started haemodialysis (HD), compared with 63% of the eGFR >15 patients (p = 0.04). The median time to starting HD was 30.3 months in the eGFR >15 group compared to 10.7 months for the eGFR ≤15 group (log rank p = 0.018). There were no differences in the requirements for a dialysis catheter (eGFR >15 24% vs. eGFR ≤15 11%, p = 0.20) or additional access procedures between the two groups.AVF surgery with an eGFR >15 ml/min/1.73 m(2) was associated with a higher risk of AVF non-use and a more prolonged time to the need for HD.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherArteriovenous Shunt, Surgical.methodsen
dc.subject.otherFemaleen
dc.subject.otherFollow-Up Studiesen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherRenal Dialysisen
dc.subject.otherRenal Insufficiency, Chronic.therapyen
dc.subject.otherRetrospective Studiesen
dc.subject.otherTime Factorsen
dc.titleClinical outcomes after arteriovenous fistula creation in chronic kidney disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleBlood Purificationen
dc.identifier.affiliationDepartment of Nephrology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1159/000360273en
dc.description.pages163-71en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/24777074en
dc.type.austinJournal Articleen
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
crisitem.author.deptNephrology-
crisitem.author.deptVascular Surgery-
crisitem.author.dept3D Medical Printing Laboratory-
crisitem.author.deptNephrology-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Jan 27, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.